Emerging Total Asset from 2010 to 2026
| EWPI Stock | USD 0.0001 0.00 0.000003% |
Check Emerging World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emerging World's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 80.1 K or Total Revenue of 0.0, as well as many indicators such as . Emerging financial statements analysis is a perfect complement when working with Emerging World Valuation or Volatility modules.
Emerging | Total Asset | Build AI portfolio with Emerging Stock |
The Total Asset trend for Emerging World Pharma offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Emerging World is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Emerging World's Total Asset Growth Pattern
Below is the plot of the Total Assets of Emerging World Pharma over the last few years. Total assets refers to the total amount of Emerging World assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Emerging World Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Emerging World's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emerging World's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.71 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Emerging Total Asset Regression Statistics
| Arithmetic Mean | 2,521,315 | |
| Geometric Mean | 2,295,287 | |
| Coefficient Of Variation | 26.02 | |
| Mean Deviation | 376,458 | |
| Median | 2,707,566 | |
| Standard Deviation | 655,990 | |
| Sample Variance | 430.3B | |
| Range | 2.9M | |
| R-Value | 0.26 | |
| Mean Square Error | 428.1B | |
| R-Squared | 0.07 | |
| Significance | 0.31 | |
| Slope | 33,694 | |
| Total Sum of Squares | 6.9T |
Emerging Total Asset History
About Emerging World Financial Statements
Investors use fundamental indicators, such as Emerging World's Total Asset, to determine how well the company is positioned to perform in the future. Although Emerging World's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Assets | 3.1 M | 1.6 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Emerging World Correlation against competitors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is there potential for Drug Manufacturers - Specialty & Generic market expansion? Will Emerging introduce new products? Factors like these will boost the valuation of Emerging World. Projected growth potential of Emerging fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0) |
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Emerging World's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emerging World should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Emerging World's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.